Skip to main content
FinSpry Logo
FinSpry
ALLR logo
ALLR
(NASDAQ)
Allarity Therapeutics, Inc.
$1.27-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Allarity Therapeutics (ALLR) Stock Price & Financial Analysis

Allarity Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.29 - $1.35
52-Week High$2.35
52-Week Low$0.77
Open$1.33
Volume68.71K
Average Volume (3M)214.92K
Market Cap18.69M
Shares Outstanding14.38M
Price to Sales (P/S)28.11
Price to Book (P/B)1.90
EV/EBITDA-0.45
Revenue (TTM)665.00K
Net Income (TTM)-12.30M
Free Cash Flow (TTM)-14.45M
EPS (TTM)$-0.81
Profit Margin-1849.92%
Operating Margin-1660.45%
Return on Equity (ROE)-125.17%
Debt to Equity0.14
50-Day MA$1.47
200-Day MA$1.29
52-Week Change23.81%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Allarity Therapeutics

What is the current stock price for ALLR?

As of the latest trading session, ALLR stock trades at $1.30. The 52-week range is $0.77–$2.35, with a day range of $1.28–$1.35.

What is the P/E ratio for ALLR?

The P/E ratio (Price-to-Earnings) for ALLR is shown in the Key Statistics section. This valuation metric helps compare Allarity Therapeutics, Inc. to industry peers.

Does ALLR pay dividends?

Allarity Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ALLR?

Based on 1 analyst, the consensus for ALLR is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ALLR?

Allarity Therapeutics's market capitalization is $18.7M, classifying it as a micro-cap company. Allarity Therapeutics operates in the Healthcare sector within the Biotechnology industry.